Acne Vulgaris


 Acne Vulgaris Acne Treatment
WTRF Healthwatch for Nov. 2

Getting enough rest could make a difference in your brain power, and a drug once thought to help those with Lou Gehrig's disease actually doesn't.

Story by The CBS Newspath

A few nights without sleep can not only make people tired and grumpy but may actually put the brain into a primitive state. Brain images of otherwise healthy men and women showed two full days without sleep seemed to rewire their brains, re-directing activity from the calming and rational areas to the more primal "fear center."

The findings may shed light on psychiatric disorders as this experiment shows even healthy people s brains can mimic pathological patterns when pushed enough.

According to a new study, women treated for pre-cancerous lesions are more than twice as likely to develop cervical cancer for at least another 25 years.


Chris Gibson, Author of the Book, "Acne Free in 3 Days," Believes Antibiotics are a Problematic Treatment Choice for ...

Health experts say overuse of antibiotics has contributed to the rapid spread of MRSA. The public health concern of growing antimicrobial resistance is a prime reason 50% of dermatologists report cutting back on antibiotics to treat acne according to the Galderma Quality Report for Dermatology and Managed Care. Chris Gibson, a holistic health and lifestyle coach and author of the book, "Acne Free in 3 Days," believes antibiotics are a problematic treatment choice for acne. He urges parents to be cautious when seeking an acne regimen that's safe and effective for kids. .


Medicis Reports Third Quarter 2007 Financial Results

SCOTTSDALE, Ariz., Nov. 7, 2007 (PRIME NEWSWIRE) -- Medicis (NYSE:MRX - News) today announced non-U.S. generally accepted accounting principles (``non-GAAP'') revenue for the three months ended September 30, 2007 of approximately $120.4 million, compared to approximately $90.0 million for the three months ended September 30, 2006, representing a year-over-year increase of approximately 34%. This increase was primarily due to strength in our acne products, namely SOLODYN(R) and ZIANA(R). Non-GAAP net income for the three months ended September 30, 2007 was approximately $24.1 million, or approximately $0.36 per diluted share, compared to non-GAAP net income of $12.9 million, or $0.21 per diluted share, for the three months ended September 30, 2006.

.


 
Link to us - Contact us